Laser Therapy for Male Pattern Baldness and Scarring Alopecia

This trial tests a laser treatment to address hair loss from male pattern baldness or scarring. It focuses on using the Sciton HALO 1470nm laser for these conditions. The trial seeks healthy adults who have experienced hair loss for at least six months and maintain a stable hair loss treatment plan. Participants must be non-smokers and agree not to change their hair care routine during the study. As an unphased trial, this study provides a unique opportunity to contribute to innovative research in hair loss treatment.

The trial requires that you stop using minoxidil or 5-alpha reductase inhibitors (like finasteride or dutasteride) at least 3 months before joining. You also cannot have used immunosuppressive medications, Accutane, or other systemic retinoids in the past 6 to 12 months.

Research has shown that the Sciton HALO 1470nm Non-ablative laser is being tested for treating hair loss conditions like male pattern baldness and scarring alopecia. Although specific safety data for these conditions is not yet available, HALO lasers are known for being non-ablative, meaning they don't remove any layers of skin. This characteristic usually suggests the treatment is likely to be well-tolerated.

Researchers are excited about the Sciton HALO 1470nm Non-ablative laser for male pattern baldness and scarring alopecia because it offers a new approach compared to traditional treatments like medications and hair transplants. This laser treatment targets hair loss with precision by using a specific wavelength (1470nm) that can penetrate the scalp without damaging the surface, potentially stimulating hair growth and improving scalp health. The quick treatment time of just 10 to 15 minutes per session is another advantage, making it a convenient option for patients. Furthermore, this non-invasive laser therapy could reduce the risk of side effects associated with more invasive procedures, making it a promising alternative for those seeking effective hair restoration solutions.

Research has shown that the Sciton HALO 1470nm laser could help with male pattern baldness and hair loss due to scarring. In this trial, participants will be divided into two groups: one targeting androgenetic alopecia (male pattern baldness) and the other targeting scarring alopecia. For male pattern baldness, studies suggest that this laser might increase hair thickness and growth by stimulating hair follicles without harming the skin's surface. For hair loss from scarring, early research indicates that the laser can reduce scars and encourage hair to grow back by reaching deeper skin layers. The laser uses specific light wavelengths to promote healing and hair growth while keeping recovery time short. Although more research is needed, these early results are promising for people dealing with hair loss and scarring.¹²³⁵⁶